Profile of tedizolid phosphate and its potential in the treatment of acute bacterial skin and skin structure infections
Ronald G Hall 2nd, Heidi N Michaels Texas Tech University Health Sciences Center, Dallas, TX, USA Abstract: Tedizolid phosphate is the first once-daily oxazolidinone approved by the United States Food and Drug Administration for the treatment of acute bacterial skin and skin structure infections (A...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2015-04-01
|
| Series: | Infection and Drug Resistance |
| Online Access: | http://www.dovepress.com/profile-of-tedizolid-phosphate-and-its-potential-in-the-treatment-of-a-peer-reviewed-article-IDR |